Summary & Overview
CPT 0864T: Low‑Intensity Shockwave Therapy to Corpus Cavernosum
CPT code 0864T designates low‑intensity extracorporeal shockwave therapy applied to the corpus cavernosum for erectile dysfunction. The code captures a device‑based, noninvasive therapeutic procedure increasingly discussed in urologic practice for patients seeking alternatives to pharmacologic treatments. Nationally, its use matters because it represents a growing category of outpatient, technology‑driven interventions with variable payer coverage and evolving clinical evidence.
Key payers in scope include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical intent and service context, payer coverage considerations, and where to look for benchmarks and policy updates. The publication summarizes typical sites of service, common billing modifiers (input provided), and highlights gaps where input data are not available. It also outlines what clinicians and billing professionals should expect in coding and claims submission processes, and identifies areas—such as evidence development and payer medical policy—where changes could affect utilization and reimbursement nationally.
Billing Code Overview
CPT code 0864T describes a procedure in which the provider uses a device to deliver low–intensity shockwaves to erectile tissue (the corpus cavernosum). This service is a therapeutic, device-based intervention targeting vascular and tissue mechanisms involved in erectile function.
-
Service type: Low‑intensity extracorporeal shockwave therapy for erectile tissue
-
Typical site of service: Ambulatory surgical center or physician office outpatient setting where device-based, noninvasive urologic procedures are performed
Data not available in the input for associated taxonomies, ICD-10 diagnoses, or related codes.
Clinical & Coding Specifications
Clinical Context
A 58-year-old male presents to a urology clinic with a 12–month history of erectile dysfunction that is refractory to oral phosphodiesterase-5 inhibitors and intracavernosal injection trials. After a focused history and physical exam, and discussion of treatment options, the patient elects low‑intensity extracorporeal shockwave therapy (Li-ESWT) targeted to the corpus cavernosum. The typical clinical workflow: the patient completes pre-procedure counseling, consent, and baseline questionnaires (including International Index of Erectile Function). Vital signs and a focused genitourinary exam are performed. The treatment is delivered in an outpatient clinic or ambulatory surgery center using a device that applies low‑intensity shockwaves to bilateral corpora cavernosa over several treatment sessions (commonly weekly for 3–6 weeks). Each session includes device setup, patient positioning, targeted application to penile shaft and crura, monitoring for discomfort, and brief post-procedure assessment. Documentation includes indication, informed consent, device used, anatomical sites treated, energy settings or pulses delivered, number and timing of sessions, any complications or intolerance, and follow-up plan for efficacy assessment.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required to perform Li-ESWT is substantially greater than typical (rare for this code; document rationale and duration). |